Cargando…

Establishment of CRFK cells for vaccine production by inactivating endogenous retrovirus with TALEN technology

Endogenous retroviruses (ERVs) are retroviral sequences present in the host genomes. Although most ERVs are inactivated, some are produced as replication-competent viruses from host cells. We previously reported that several live-attenuated vaccines for companion animals prepared using the Crandell-...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimode, Sayumi, Sakuma, Tetsushi, Yamamoto, Takashi, Miyazawa, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046391/
https://www.ncbi.nlm.nih.gov/pubmed/35477976
http://dx.doi.org/10.1038/s41598-022-10497-1
_version_ 1784695513741787136
author Shimode, Sayumi
Sakuma, Tetsushi
Yamamoto, Takashi
Miyazawa, Takayuki
author_facet Shimode, Sayumi
Sakuma, Tetsushi
Yamamoto, Takashi
Miyazawa, Takayuki
author_sort Shimode, Sayumi
collection PubMed
description Endogenous retroviruses (ERVs) are retroviral sequences present in the host genomes. Although most ERVs are inactivated, some are produced as replication-competent viruses from host cells. We previously reported that several live-attenuated vaccines for companion animals prepared using the Crandell-Rees feline kidney (CRFK) cell line were contaminated with a replication-competent feline ERV termed RD-114 virus. We also found that the infectious RD-114 virus can be generated by recombination between multiple RD-114 virus-related proviruses (RDRSs) in CRFK cells. In this study, we knocked out RDRS env genes using the genome-editing tool TAL Effector Nuclease (TALEN) to reduce the risk of contamination by infectious ERVs in vaccine products. As a result, we succeeded in establishing RDRS knockout CRFK cells (RDKO_CRFK cells) that do not produce infectious RD-114 virus. The growth kinetics of feline herpesvirus type 1, calicivirus, and panleukopenia virus in RDKO_CRFK cells differed from those in parental cells, but all of them showed high titers exceeding 10(7) TCID(50)/mL. Infectious RD-114 virus was undetectable in the viral stocks propagated in RDKO_CRFK cells. This study suggested that RDRS env gene-knockout CRFK cells will be useful as a cell line for the manufacture of live-attenuated vaccines or biological substances with no risk of contamination with infectious ERV.
format Online
Article
Text
id pubmed-9046391
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-90463912022-04-29 Establishment of CRFK cells for vaccine production by inactivating endogenous retrovirus with TALEN technology Shimode, Sayumi Sakuma, Tetsushi Yamamoto, Takashi Miyazawa, Takayuki Sci Rep Article Endogenous retroviruses (ERVs) are retroviral sequences present in the host genomes. Although most ERVs are inactivated, some are produced as replication-competent viruses from host cells. We previously reported that several live-attenuated vaccines for companion animals prepared using the Crandell-Rees feline kidney (CRFK) cell line were contaminated with a replication-competent feline ERV termed RD-114 virus. We also found that the infectious RD-114 virus can be generated by recombination between multiple RD-114 virus-related proviruses (RDRSs) in CRFK cells. In this study, we knocked out RDRS env genes using the genome-editing tool TAL Effector Nuclease (TALEN) to reduce the risk of contamination by infectious ERVs in vaccine products. As a result, we succeeded in establishing RDRS knockout CRFK cells (RDKO_CRFK cells) that do not produce infectious RD-114 virus. The growth kinetics of feline herpesvirus type 1, calicivirus, and panleukopenia virus in RDKO_CRFK cells differed from those in parental cells, but all of them showed high titers exceeding 10(7) TCID(50)/mL. Infectious RD-114 virus was undetectable in the viral stocks propagated in RDKO_CRFK cells. This study suggested that RDRS env gene-knockout CRFK cells will be useful as a cell line for the manufacture of live-attenuated vaccines or biological substances with no risk of contamination with infectious ERV. Nature Publishing Group UK 2022-04-27 /pmc/articles/PMC9046391/ /pubmed/35477976 http://dx.doi.org/10.1038/s41598-022-10497-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Shimode, Sayumi
Sakuma, Tetsushi
Yamamoto, Takashi
Miyazawa, Takayuki
Establishment of CRFK cells for vaccine production by inactivating endogenous retrovirus with TALEN technology
title Establishment of CRFK cells for vaccine production by inactivating endogenous retrovirus with TALEN technology
title_full Establishment of CRFK cells for vaccine production by inactivating endogenous retrovirus with TALEN technology
title_fullStr Establishment of CRFK cells for vaccine production by inactivating endogenous retrovirus with TALEN technology
title_full_unstemmed Establishment of CRFK cells for vaccine production by inactivating endogenous retrovirus with TALEN technology
title_short Establishment of CRFK cells for vaccine production by inactivating endogenous retrovirus with TALEN technology
title_sort establishment of crfk cells for vaccine production by inactivating endogenous retrovirus with talen technology
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046391/
https://www.ncbi.nlm.nih.gov/pubmed/35477976
http://dx.doi.org/10.1038/s41598-022-10497-1
work_keys_str_mv AT shimodesayumi establishmentofcrfkcellsforvaccineproductionbyinactivatingendogenousretroviruswithtalentechnology
AT sakumatetsushi establishmentofcrfkcellsforvaccineproductionbyinactivatingendogenousretroviruswithtalentechnology
AT yamamototakashi establishmentofcrfkcellsforvaccineproductionbyinactivatingendogenousretroviruswithtalentechnology
AT miyazawatakayuki establishmentofcrfkcellsforvaccineproductionbyinactivatingendogenousretroviruswithtalentechnology